Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.
The application of hepatocyte growth factor includes oncology, cardiovascular, central nervous system, hematological disorders and others, and the proportion of R&D Investment for oncology in 2017 is about 36%, and the proportion is in decreasing trend from 2012 to 2016.
Asia Pacific will be the largest market, which will occupy nearly 62% market share in 2030. Following Asia Pacific, North America will be the second largest market with the consumption market share of 25% in 2030.
The global Hepatocyte Growth Factor market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Hepatocyte Growth Factor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hepatocyte Growth Factor market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
ViroMed
AnGes MG
M3 Biotechnology
AVEO Pharmaceuticals
Molecular Partners
Yooyoung Pharm
F-star
Galaxy Biotech
Kringle Pharma
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Type I
Type II
Segment by Application
Oncology
Cardiovascular
Central Nervous System
Hematological Disorders
Others
Table of Contents
Executive Summary
1 Hepatocyte Growth Factor Market Overview
1.1 Product Overview and Scope of Hepatocyte Growth Factor
1.2 Hepatocyte Growth Factor Segment by Type
1.2.1 Global Hepatocyte Growth Factor Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Type I
1.2.3 Type II
1.3 Hepatocyte Growth Factor Segment by Application
1.3.1 Hepatocyte Growth Factor Consumption Comparison by Application (2014-2025)
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous System
1.3.5 Hematological Disorders
1.3.6 Others
1.3 Global Hepatocyte Growth Factor Market by Region
1.3.1 Global Hepatocyte Growth Factor Market Size Region
1.3.2 North America Status and Prospect (2014-2025)
1.3.3 Europe Status and Prospect (2014-2025)
1.3.4 China Status and Prospect (2014-2025)
1.3.5 Japan Status and Prospect (2014-2025)
1.3.6 Southeast Asia Status and Prospect (2014-2025)
1.3.7 India Status and Prospect (2014-2025)
1.4 Global Hepatocyte Growth Factor Market Size
1.4.1 Global Hepatocyte Growth Factor Revenue (2014-2025)
1.4.2 Global Hepatocyte Growth Factor Production (2014-2025)
2 Global Hepatocyte Growth Factor Market Competition by Manufacturers
2.1 Global Hepatocyte Growth Factor Production Market Share by Manufacturers (2014-2019)
2.2 Global Hepatocyte Growth Factor Revenue Share by Manufacturers (2014-2019)
2.3 Global Hepatocyte Growth Factor Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Hepatocyte Growth Factor Production Sites, Area Served, Product Types
2.5 Hepatocyte Growth Factor Market Competitive Situation and Trends
Summary: Get latest Market Research Reports on Hepatocyte Growth Factor . Industry analysis & Market Report on Hepatocyte Growth Factor is a syndicated market report, published as Global Hepatocyte Growth Factor Market Research Report 2019. It is complete Research Study and Industry Analysis of Hepatocyte Growth Factor market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.